• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

临床输血与检验 ›› 2026, Vol. 28 ›› Issue (5): 733-739.DOI: 10.3969/j.issn.1671-2587.2026.05.010

• 临床输血 • 上一篇    下一篇

基于大样本数据的中国人群RhCE表型输血致敏风险量化模型构建与评估

于建, 李兴龙, 屠嘉欣, 鲍莉坤, 朱长太   

  1. 上海交通大学医学院附属第六人民医院输血科,上海 200233
  • 收稿日期:2026-09-05 修回日期:2026-09-21 出版日期:2026-10-20 发布日期:2026-11-11
  • 通讯作者: 朱长太,主要从事临床输血医学与管理方面研究,(E-mail)zct101@163.com。
  • 作者简介:于建,主要从事疑难血型血清学与分子生物学研究,(E-mail)984983883@qq.com。

A Large-Scale Quantitative Model of RhCE-Related Transfusion Alloimmunization Risk in the Chinese Population

YU Jian, LI Xinglong, TU Jiaxin, BAO Likun, ZHU Changtai   

  1. Department of Blood Transfusion, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233
  • Received:2026-09-05 Revised:2026-09-21 Online:2026-10-20 Published:2026-11-11

摘要: 目的 评估不同RhCE表型患者在随机输血条件下的累积新抗原暴露概率及模型化免疫风险,为精准输血拟议策略提供量化依据。方法 本研究为二次分析:汇集赵桐茂报告的8项研究共计458 542例中国人群RhD、C、c、E、e抗原分型数据,确认其符合Hardy-Weinberg平衡。采用最大似然估计法计算Rh单倍型频率及RHCE等位基因频率。在此基础上,运用独立事件累积概率模型,计算9种RhD阳性表型在1~5次随机输血下的新抗原累积暴露概率,构建加权免疫风险指数RI(Risk Index),综合评估各表型的免疫致敏风险。RI为本模型导出的综合评分,并不等同于临床实际同种免疫发生率。结果 中国人群中最常见的单倍型是DCe(65.80%),其次是DcE(24.77%),DCCee表型(占人群46.00%)是最高危群体,单次输血新抗原(E、c)暴露的概率达53.77%,5次输血后累积概率升至97.89%,模型RI约43.95,属于模型定义高风险。DCcEe表型(占人群33.58%)因同时携带C、c、E、e四种抗原,其输血相关RhCE新抗原暴露概率在本模型条件下恒为0%,但仅限RhCE系统,并非临床万能受者。缺乏e抗原的纯合子表型(如DCcEE),随机输血导致e抗原暴露几乎不可避免,多次输血后累积概率接近100%,但因e抗原免疫原性极低(权重0.071),模型RI有限。结论 中国人群RhCE表型分布极不均匀,DCCee表型是精准拟议输血策略的首要靶标群体。模型结果显示,L1-A目标抗原回避与L1-B(C/c/E/e)完全表型匹配均可将目标RhCE新抗原暴露概率降至0%,但二者供者选择范围不同、临床实施难度存在差异,且上述策略并不能等同于完全消除临床致敏风险。DCcEe表型仅在RhCE系统内可视为“全抗原携带者”,并非临床万能受者,仍可因其他血型系统发生同种免疫。基于上述模型推演,建议将RhCE分型逐步纳入输血前检测,对高危表型以及需长期输血的患者尽早启动RhCE匹配拟议策略,最大限度降低同种免疫发生风险;上述具体策略仍有待多中心前瞻性研究进一步验证。

关键词: Rh血型系统, RhCE抗原匹配, 精准输血, 同种免疫, Hardy-Weinberg平衡, 免疫风险指数

Abstract: Objective To quantify the cumulative probability of novel antigen exposure and model-based immunological risk among individuals with distinct RhCE phenotypes under random transfusion conditions, thereby providing a quantitative rationale for proposed precision transfusion strategies. Methods This was a secondary analysis. We pooled RhD, C, c, E, and e antigen typing data from 458 542 Chinese individuals across eight studies reported by Zhao Tongmao, and confirmed Hardy-Weinberg equilibrium. Maximum-likelihood estimation was used to derive Rh haplotype frequencies and RHCE allele frequencies. On this basis, an independent-event cumulative probability model was applied to calculate the cumulative novel antigen exposure probability for nine RhD-positive phenotypes across one to five random transfusions, and a weighted immunological Risk Index (RI) was constructed to comprehensively assess the alloimmunization risk of each phenotype. The RI is a composite model-derived score and does not equate to the observed incidence of alloimmunization. Results The most common haplotype in the Chinese population was DCe (65.80%), followed by DcE (24.77%). The DCCee phenotype (46.00% of the population) represented the highest-risk group, with a single-transfusion novel antigen (E, c) exposure probability of 53.77%, rising to 97.89% after five transfusions, and a model-derived RI of approximately 43.95, classified as high risk by the model definition. The DCcEe phenotype (33.58% of the population), owing to its simultaneous carriage of C, c, E, and e antigens, had a transfusion-related RhCE novel antigen exposure probability of 0% under the conditions of this model; however, this applies only to the RhCE system and does not render such individuals universal recipients. For e antigen-negative homozygous phenotypes (e.g., DCcEE), random transfusion makes e antigen exposure virtually inevitable, with cumulative probability approaching 100% after multiple transfusions; nevertheless, because of the extremely low immunogenicity of the e antigen (weight 0.071), the model-derived RI remained limited. Conclusion The distribution of RhCE phenotypes in the Chinese population is highly uneven, and the DCCee phenotype constitutes the primary target population for proposed precision transfusion strategies. Model results indicate that both L1-A targeted antigen avoidance and L1-B (C/c/E/e) complete phenotype matching can reduce the probability of target RhCE novel antigen exposure to 0%; however, the two approaches differ in donor pool size and clinical feasibility, and neither should be equated with complete elimination of clinical alloimmunization risk. The DCcEe phenotype can be regarded as a "pan-antigen carrier" only within the RhCE system and is not a clinically universal recipient; alloimmunization against other blood group systems remains possible. Based on these model projections, we recommend that RhCE typing be progressively incorporated into pre-transfusion testing, and that RhCE-matched proposed strategies be initiated as early as possible for high-risk phenotypes and patients requiring long-term transfusion, so as to minimize the risk of alloimmunization; these specific strategies warrant further validation in multicenter prospective studies.

Key words: Rh blood group system, RhCE antigen matching, Precision transfusion, Alloimmunization, Hardy-Weinberg equilibrium, Immune risk index

中图分类号: